Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha, Adaptvac, Aligos, Amryt, Bavarian Nordic, Baxter, Betterlife, CASI, Cleave, Cortexyme, Exelixis, Fairjourney, Galectin, GT, Iontas, Iqvia, Johnson & Johnson, Medincell, Medison, Moderna, Pathios, Quell, Wugen, Wuxi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Aim, Alteogen, Anaptysbio, Aravive, Atea, Cytodyn, Gilead, Imara, Immunitybio, Innovation, Mayne, Merck & Co., Nantkwest, Oncoinvent, Pfizer, Ridgeback, Roche, Seres, Valneva.

Biopharmas raising money in public or private financings, including: Algernon, Azurrx, Lineage, Longboard, Prometheus.

New hires and promotions in the biopharma industry, including: Arsenalbio, Athira, Baudax, Chemocentryx, Claritas, Gritstone, Moderna, Noveome, Rezolute, Skye, Storm, Spybiotech, Synlogic, Tracon.

Quarterly snapshots from biopharma companies with marketed products, including: Insmed, La Jolla.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: CDSCO eyes recognition of ASTM standards; Device makers, docs blast radiation oncology payment model.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Illumina, Second Sight.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abc Biopply, Abclonal, Anfass Life Technologies, Asensus Surgical, Cirtec Medical, Dih Technology, Ekso Bionics, Performance Contracting, Quadira, Reha Technology, Synerfuse, Xlife Sciences, Yurogen Biosystems.

Med-tech firms raising money in public or private financings, including: Cutera, Oxehealth, Perkinelmer, Predictmedix.

New hires and promotions in the med-tech industry, including: Rinicare.